BICX BioCorRx Inc.
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%
Returns
ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x
Cash quality & payout
Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $797,244 | $7,665 | $89,160 | $213,841 | $48,272 |
| Cost of revenue | — | $1,667 | $35,986 | $15,279 | $5,881 |
| Gross profit | — | $5,998 | $53,174 | $198,562 | $42,391 |
| R&D expense | $1.77M | $1.48M | $891,063 | $1.46M | $1.61M |
| SG&A expense | $3.79M | $3.61M | $2.88M | $3.41M | $3.74M |
| Operating income | -$4.83M | -$5.12M | -$3.79M | -$4.70M | -$5.51M |
| Interest expense | $223,850 | $776,780 | $194,041 | $150,969 | $19,424 |
| Pretax income | -$3.51M | -$5.21M | -$3.77M | -$4.38M | -$5.21M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$3.44M | -$5.11M | -$3.77M | -$4.38M | -$5.21M |
| EBITDA | -$4.79M | -$5.09M | -$3.76M | -$4.67M | -$5.45M |
| EPS (basic) | — | — | — | — | -0.81 |
| EPS (diluted) | -0.19 | -0.49 | — | — | -0.81 |
| Weighted avg. shares (diluted) | 18.49M | 10.46M | 2.70M | 1.45M | 1.06M |
| Banking | |||||
| Net interest income | — | — | — | — | -$565,684 |
| Noninterest income | — | $105,978 | $3,577 | $7,419 | $2,384 |
| Balance sheet | |||||
| Cash & equivalents | $139,360 | $88,033 | $65,222 | $68,615 | $85,838 |
| Receivables | $253,459 | $0 | $740 | $35,378 | — |
| Inventory | $143,425 | $0 | — | — | — |
| Current assets | $814,468 | $117,996 | $187,119 | $316,910 | $228,326 |
| PP&E, net | $4,062 | $18,977 | $50,943 | $76,572 | $102,843 |
| Goodwill | $563,158 | $0 | — | — | — |
| Intangibles | $564,460 | $7,848 | $9,027 | $10,206 | $11,385 |
| Total assets | $2.15M | $385,941 | $388,887 | $766,594 | $819,975 |
| Current liabilities | $8.31M | $8.21M | $6.43M | $5.36M | $4.39M |
| Short-term debt | $0 | — | — | $0 | $31,580 |
| Long-term debt | — | — | — | $0 | $99,860 |
| Total debt | — | — | — | $0 | $131,440 |
| Total liabilities | $13.67M | $12.74M | $10.34M | $8.97M | $7.78M |
| Shareholders' equity | -$11.22M | -$12.12M | -$9.82M | -$8.08M | -$6.96M |
| Net debt | — | — | — | -$68,615 | $45,602 |
| Shares outstanding | 24.49M | 13.30M | 8.67M | 7.72M | 6.70M |
| Cash flow statement | |||||
| Operating cash flow | -$2.30M | -$1.10M | -$1.85M | -$2.04M | -$3.54M |
| Capital expenditure | — | — | — | $0 | $2,017 |
| Free cash flow | — | — | — | -$2.04M | -$3.54M |
| Investing cash flow | — | — | — | $0 | -$49,997 |
| Financing cash flow | $2.35M | $1.12M | $1.85M | $2.02M | $3.08M |
| Depreciation & amortization | $44,003 | $33,145 | $26,808 | $27,450 | $64,328 |
| Stock-based compensation | $592,604 | $1.22M | $63,941 | $354,509 | $209,515 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.